Company Description
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.
The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products.
It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.
It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.
The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024.
Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
| Country | United States |
| Founded | 2022 |
| IPO Date | Feb 21, 2025 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| CEO | Prashant Patel |
Contact Details
Address: 3000 Bayport Drive, Suite 950 Tampa, Florida 33607 United States | |
| Phone | 844 203 6092 |
| Website | wellgisticshealth.com |
Stock Details
| Ticker Symbol | WGRX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.50 |
| CIK Code | 0002030763 |
| CUSIP Number | 949503106 |
| ISIN Number | US9495031067 |
| Employer ID | 93-3264234 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Tony Madsen | Chief Operating Officer |
| Srinivas Kalla | Chief Information Officer |
| Shelley Bailey | Chief Revenue Officer |
| Ari Aichbhaumik | Senior Vice President of Supply Chain |
| Jason Lang | President of Distribution |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 17, 2025 | 8-K | Current Report |
| Oct 10, 2025 | 8-K | Current Report |
| Oct 6, 2025 | 8-K | Current Report |
| Oct 1, 2025 | 8-K | Current Report |
| Sep 29, 2025 | 424B4 | Prospectus |
| Sep 25, 2025 | EFFECT | Notice of Effectiveness |
| Sep 22, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Sep 12, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Sep 8, 2025 | 8-K | Current Report |
| Aug 29, 2025 | 8-K | Current Report |